Literature DB >> 18344451

Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration.

Curtis L Nordgaard1, Pabalu P Karunadharma, Xiao Feng, Timothy W Olsen, Deborah A Ferrington.   

Abstract

PURPOSE: Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over the age of 65. Histopathological changes become evident in the retinal pigment epithelium (RPE), a monolayer that provides metabolic support for the overlying photoreceptors, even at the earliest stages of AMD that precede vision loss. In a previous global RPE proteome analysis, changes were identified in the content of several mitochondrial proteins associated with AMD. In this study, the subproteome of mitochondria isolated from human donor RPE graded with the Minnesota Grading System (MGS) was analyzed.
METHODS: Human donor eye bank eyes were categorized into one of four progressive stages (MGS 1-4) based on the clinical features of AMD. After dissection of the RPE, mitochondrial proteins were isolated and separated by two-dimensional gel electrophoresis based on their charge and mass. Protein spot densities were compared between the four MGS stages. Peptides from spots that changed significantly with MGS stage were extracted and analyzed by using mass spectrometry to identify the protein.
RESULTS: Western blot analyses verified that mitochondria were consistently enriched between MGS stages. The densities of eight spots increased or decreased significantly as a function of MGS stage. These spots were identified as the alpha-, beta-, and delta-ATP synthase subunits, subunit VIb of the cytochrome c oxidase complex, mitofilin, mtHsp70, and the mitochondrial translation factor Tu.
CONCLUSIONS: The results are consistent with the hypothesis that mitochondrial dysfunction is associated with AMD and further suggest specific pathophysiological mechanisms involving altered mitochondrial translation, import of nuclear-encoded proteins, and ATP synthase activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344451      PMCID: PMC4397576          DOI: 10.1167/iovs.07-1352

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  46 in total

1.  Blue light induces mitochondrial DNA damage and free radical production in epithelial cells.

Authors:  Bernard F Godley; Farrukh A Shamsi; Fong-Qi Liang; Stuart G Jarrett; Sallyanne Davies; Mike Boulton
Journal:  J Biol Chem       Date:  2005-03-29       Impact factor: 5.157

2.  The inhibitor protein (IF1) promotes dimerization of the mitochondrial F1F0-ATP synthase.

Authors:  José J García; Edgar Morales-Ríos; Paulina Cortés-Hernandez; José S Rodríguez-Zavala
Journal:  Biochemistry       Date:  2006-10-24       Impact factor: 3.162

3.  Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs.

Authors:  Jan A M Smeitink; Orly Elpeleg; Hana Antonicka; Heleen Diepstra; Ann Saada; Paulien Smits; Florin Sasarman; Gert Vriend; Jasmine Jacob-Hirsch; Avraham Shaag; Gideon Rechavi; Brigitte Welling; Jurgen Horst; Richard J Rodenburg; Bert van den Heuvel; Eric A Shoubridge
Journal:  Am J Hum Genet       Date:  2006-09-15       Impact factor: 11.025

Review 4.  Recognition and selection of tRNA in translation.

Authors:  Marina V Rodnina; Kirill B Gromadski; Ute Kothe; Hans-Joachim Wieden
Journal:  FEBS Lett       Date:  2005-02-07       Impact factor: 4.124

5.  Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells.

Authors:  S W Ballinger; B Van Houten; G F Jin; C A Conklin; B F Godley
Journal:  Exp Eye Res       Date:  1999-06       Impact factor: 3.467

6.  Proteome analysis reveals phosphorylation of ATP synthase beta -subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes.

Authors:  Kurt Højlund; Krzysztof Wrzesinski; Peter Mose Larsen; Stephen J Fey; Peter Roepstorff; Aase Handberg; Flemming Dela; Jørgen Vinten; James G McCormack; Christine Reynet; Henning Beck-Nielsen
Journal:  J Biol Chem       Date:  2003-01-16       Impact factor: 5.157

7.  Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration.

Authors:  Alejandra Decanini; Curtis L Nordgaard; Xiao Feng; Deborah A Ferrington; Timothy W Olsen
Journal:  Am J Ophthalmol       Date:  2007-02-05       Impact factor: 5.258

8.  Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study.

Authors:  Helena Buch; Troels Vinding; Morten La Cour; Merete Appleyard; Gorm B Jensen; Niels Vesti Nielsen
Journal:  Ophthalmology       Date:  2004-01       Impact factor: 12.079

9.  Pigmentary retinopathy in patients with the MELAS mutation 3243A-->G in mitochondrial DNA.

Authors:  Terho Latvala; Eila Mustonen; Raimo Uusitalo; Kari Majamaa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-09-21       Impact factor: 3.117

10.  The yeast counterparts of human 'MELAS' mutations cause mitochondrial dysfunction that can be rescued by overexpression of the mitochondrial translation factor EF-Tu.

Authors:  M Feuermann; S Francisci; T Rinaldi; C De Luca; H Rohou; L Frontali; M Bolotin-Fukuhara
Journal:  EMBO Rep       Date:  2003-01       Impact factor: 8.807

View more
  82 in total

1.  Mitochondrial DNA damage and repair in RPE associated with aging and age-related macular degeneration.

Authors:  Haijiang Lin; Haifeng Xu; Fong-Qi Liang; Hao Liang; Praveena Gupta; Anna N Havey; Michael E Boulton; Bernard F Godley
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

2.  Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration.

Authors:  Pabalu P Karunadharma; Curtis L Nordgaard; Timothy W Olsen; Deborah A Ferrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

3.  Mitochondrial proteomic analysis of isopsoralen protection against oxidative damage in human lens epithelial cells.

Authors:  Chun-Yan Feng; Xiu-Rong Huang; Ming-Xin Qi; Song-Wen Tang; Yan-Hong Hu; Sheng Chen; Fa-Jie Ke
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

4.  Early biosignature of oxidative stress in the retinal pigment epithelium.

Authors:  Hilal Arnouk; Hyunju Lee; Ruonan Zhang; Hyewon Chung; Richard C Hunt; Wan Jin Jahng
Journal:  J Proteomics       Date:  2010-11-11       Impact factor: 4.044

Review 5.  Molecular pathology of age-related macular degeneration.

Authors:  Xiaoyan Ding; Mrinali Patel; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2008-11-06       Impact factor: 21.198

Review 6.  Genetics of age-related macular degeneration: current concepts, future directions.

Authors:  Margaret M Deangelis; Alexandra C Silveira; Elizabeth A Carr; Ivana K Kim
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

7.  Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration.

Authors:  Haoyu Mao; Soo Jung Seo; Manas R Biswal; Hong Li; Mandy Conners; Arathi Nandyala; Kyle Jones; Yun-Zheng Le; Alfred S Lewin
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-01       Impact factor: 4.799

8.  Quantitative proteomics: comparison of the macular Bruch membrane/choroid complex from age-related macular degeneration and normal eyes.

Authors:  Xianglin Yuan; Xiaorong Gu; John S Crabb; Xiuzhen Yue; Karen Shadrach; Joe G Hollyfield; John W Crabb
Journal:  Mol Cell Proteomics       Date:  2010-02-22       Impact factor: 5.911

9.  Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry.

Authors:  Bent Honoré; Henrik Vorum; Nakul Mandal; Steffen Heegaard; Jan Ulrik Prause
Journal:  Biol Proced Online       Date:  2009-12-24       Impact factor: 3.244

10.  DNA damage/repair and polymorphism of the hOGG1 gene in lymphocytes of AMD patients.

Authors:  Katarzyna Wozniak; Jacek P Szaflik; Malgorzata Zaras; Anna Sklodowska; Katarzyna Janik-Papis; Tomasz R Poplawski; Janusz Blasiak; Jerzy Szaflik
Journal:  J Biomed Biotechnol       Date:  2009-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.